SCHEMBL4762887

SCHEMBL4762887

c1ccc(C[N]Oc2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
MIF P14174 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 3/20 0.39
LTA4H P09960 3/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2B Q13224 2/20 0.38
KMT2A Q03164 1/20 0.38
NOS2 P35228 1/20 0.38
CALM1 P0DP23 1/20 0.38
KCNA3 P22001 1/20 0.37
IDO1 P14902 2/20 0.36
DRD4 P21917 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8251 0.73 NOS2 (0.43) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL5902338 0.73 CA4 (0.42) TSHRLTA4HKCNA3TP53
SCHEMBL6598540 0.71 TSHR (0.50) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL1653 0.70 ALDH1A1 (0.55) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL9872012 0.70 LTA4H (0.41) TSHRLTA4HKMT2AKCNA3
SCHEMBL11337111 0.70 TP53 (0.44) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL10667652 0.70 TSHR (0.44) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL1852892 0.70 ALDH1A1 (0.40) TRPA1ALDH1A1CYP3A4MIFHPGD
SCHEMBL453564 0.69
SCHEMBL7462793 0.68 TRPA1 (0.39) TRPA1ALDH1A1CYP3A4MIFHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1885349-A2 SULPHAMIDES FOR TREATMENT OF CANCER Merck Sharp & Dohme Limited (GB) 2008-02-13 EP disclosed
WO-2006123185-A2 SULPHAMIDES FOR TREATMENT OF CANCER MERCK SHARP & DOHME LIMITED (GB) 2006-11-23 WO disclosed